Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01FFX
|
|||
Former ID |
DNC009134
|
|||
Drug Name |
4-((naphthalen-2-yloxy)methyl)piperidine
|
|||
Synonyms |
4-[(2-Naphthyloxy)methyl]piperidine; CHEMBL453996; 4-((naphthalen-2-yloxy)methyl)piperidine; 946680-75-7; 4-[(naphthalen-2-yloxy)methyl]piperidine; CTK7D1529; ZINC14631494; BDBM50278526; AKOS000172158
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H19NO
|
|||
Canonical SMILES |
C1CNCCC1COC2=CC3=CC=CC=C3C=C2
|
|||
InChI |
1S/C16H19NO/c1-2-4-15-11-16(6-5-14(15)3-1)18-12-13-7-9-17-10-8-13/h1-6,11,13,17H,7-10,12H2
|
|||
InChIKey |
MUOXAGUZMVATIC-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1. Bioorg Med Chem Lett. 2009 Apr 15;19(8):2329-32. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.